Alzheimer’s Dementia – Medical Marijuana

The influence of cannabinoids on generic traits of neurodegeneration

By admin| 2016-06-24T13:32:46+01:00 June 24th, 2016|

Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease

By admin| 2016-06-24T13:26:40+01:00 June 24th, 2016|

Natural Phytochemicals in the Treatment and Prevention of Dementia- An Overview

By admin| 2016-06-24T13:21:38+01:00 June 24th, 2016|

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia

By admin| 2016-06-24T13:19:22+01:00 June 24th, 2016|

Cannabinoids for treatment of Alzheimer’s disease- moving toward the clinic

By admin| 2016-06-24T13:18:28+01:00 June 24th, 2016|

Cannabinoids for the treatment of dementia

By admin| 2016-06-24T13:16:51+01:00 June 24th, 2016|

Cannabinoids and Dementia- A Review of Clinical and Preclinical Data

By admin| 2016-06-24T13:16:05+01:00 June 24th, 2016|

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo_ relevance to Alzheimer’s disease

By admin| 2016-06-24T13:14:52+01:00 June 24th, 2016|

Amyloid-beta inhibits E-S Potentiation through suppression of cannabinoid receptor 1 dependent synaptic disinhibition

By admin| 2016-06-24T13:13:54+01:00 June 24th, 2016|

A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology

By admin| 2016-06-24T13:12:02+01:00 June 24th, 2016|